EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)

A phase 1 open‐label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy

Vibhor Krishna iD, Jesse Mindel, Francesco Sammartino, Cady Block, Alok Kumar Dwivedi, Jamie J Van Gompel iD, Nathan Fountain iD, Robert Fisher iD

Epilepsia · 2023-04 · 64 (4) · 831-842

DOI: 10.1111/epi.17535 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Epilepsia, 2023-03. Verfasst von Vibhor Krishna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of North Carolina, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Epilepsies, Partial, Anterior Thalamic Nuclei. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Focused Ultrasound Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Focused ultrasound ablation (FUSA) is an emerging treatment for neurological and psychiatric diseases. We describe the initial experience from a pilot, open‐label, single‐center clinical trial of unilateral anterior nucleus of the thalamus (ANT) FUSA in patients with treatment‐refractory epilepsy.

Methods

Two adult subjects with treatment‐refractory, focal onset epilepsy were recruited. The subjects received ANT FUSA using the Exablate Neuro (Insightec) system. We determined the safety and feasibility (primary outcomes), and changes in seizure frequency (secondary outcome) at 3, 6, and 12 months. Safety was assessed by the absence of side effects, that is, new onset neurological deficits or performance deterioration on neuropsychological testing. Feasibility was defined as the ability to create a lesion within the anterior nucleus. The monthly seizure frequency was compared between baseline and postthalamotomy.

Results

The patients tolerated the procedure well, without neurological deficits or serious adverse events. One patient experienced a decline in verbal fluency, attention/working memory, and immediate verbal memory. Seizure frequency reduced significantly in both patients; one patient was seizure‐free at 12 months, and in the second patient, the frequency reduced from 90–100 seizures per month to 3–6 seizures per month. Significance This is the first known clinical trial to assess the safety, feasibility, and preliminary efficacy of ANT FUSA in adult patients with treatment‐refractory focal onset epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, PartialAnterior Thalamic NucleiAdultHumansSeizuresAttentionTreatment Outcome

Stichwörter der Autor:innen

anterior nucleusclinical trialepilepsyfocused ultrasoundthalamotomy

Autor:innen und Institutionen

  • Department of Neurosurgery, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Department of Neurology, Ohio State University, Columbus, Ohio, USA.
  • Department of Physical Medicine and Rehabilitation, Ohio State University, Columbus, Ohio, USA.
  • Department of Neurology, Emory University, Atlanta, Georgia, USA.
  • Division of Biostatistics and Epidemiology, Texas Tech University Health Sciences Center, El Paso, Texas, USA.
  • Department of Neurosurgery and Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Vibhor Krishna, Jamie J Van Gompel, Nathan Fountain, Robert Fisher

Förderung

  • Focused Ultrasound Foundation

Zitieren

APA

Krishna, V., Mindel, J., Sammartino, F., Block, C., Dwivedi, A. K., Van Gompel, J. J., Fountain, N., & Fisher, R. (2023). A phase 1 open‐label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy. Epilepsia, 64(4), 831-842. https://doi.org/10.1111/epi.17535

Vancouver

Krishna V, Mindel J, Sammartino F, Block C, Dwivedi AK, Van Gompel JJ, et al. A phase 1 open‐label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy. Epilepsia. 2023;64(4):831-842. doi:10.1111/epi.17535

BibTeX
@article{Krishna2023,
  author = {Krishna, Vibhor and Mindel, Jesse and Sammartino, Francesco and Block, Cady and Dwivedi, Alok Kumar and Van Gompel, Jamie J and Fountain, Nathan and Fisher, Robert},
  title = {A phase 1 open‐label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy},
  journal = {Epilepsia},
  year = {2023},
  volume = {64},
  number = {4},
  pages = {831--842},
  doi = {10.1111/epi.17535}
}
Kostenlos starten →